Biotechnology in cosmetics: Polynucleotides in Aesthetic Products

Tags:

A lab scene with test tubes and a glass vial, representing biotechnology's role in enhancing quality in beauty products

23 Jul 2026

Why Biotechnology and Advanced Analytics Matter

Polynucleotides (PNs) are rapidly emerging as one of the most talked-about innovations in aesthetic medicine. Once primarily associated with regenerative medicine and wound healing, these DNA-derived biopolymers are now increasingly used in skin rejuvenation, hydration, tissue repair, and anti-aging injectable treatments. Their growing popularity reflects a wider industry shift toward regenerative aesthetics, treatments designed not simply to fill or freeze, but to stimulate natural biological repair processes.

Traditionally, polynucleotides used in aesthetic applications were sourced from animal-derived DNA, particularly marine origins such as salmon sperm DNA. Today, however, biotechnology and microbial production methods are aiming to transform the sector by enabling safer, more consistent, and more precisely controlled biomolecules. This evolution is critical because the efficacy and safety of PN-based products depend heavily on polymer size, purity, molecular consistency, and structural integrity.

Why Polynucleotides Are Trending in Aesthetics

In aesthetic medicine, PNs are commonly incorporated into injectable skin boosters and regenerative formulations intended to improve skin elasticity, texture, and recovery after procedures.

Unlike traditional fillers that primarily provide volume, polynucleotides are positioned as bioactive regenerative agents. Research suggests they may help stimulate collagen production, reduce oxidative stress, and support cellular repair mechanisms. This has led to growing interest among clinics and consumers seeking more natural-looking and biologically supportive aesthetic treatments.

The broader cosmetic and medical industries are also exploring DNA-based biomolecules for their protective and reparative functions. DNA-derived ingredients are already used in skincare formulations designed to defend against oxidative damage and promote cellular renewal, while medical applications include wound-healing scaffolds, regenerative matrices, and advanced tissue engineering systems.

The Shift Toward Microbial Biotechnology

One of the major developments in PN manufacturing is the move towards controlled microbial biotechnology processes. Microbial production platforms allow manufacturers to generate highly purified nucleic acid polymers under tightly regulated fermentation conditions.

This biotechnological approach offers several important advantages:

Improved batch-to-batch consistency
Better control of polymer size distribution
Reduced contamination risk
Enhanced scalability
Greater sustainability and traceability

Perhaps most importantly, microbial production enables tighter control over molecular weight [NS1.1]/ polymer size and polymer architecture. In polynucleotide formulations, polymer size is directly linked to biological activity, tissue interaction, injectability, and degradation behavior. Variations in polymer length can significantly alter product performance, stability, and safety. Polymer size can be measured by either capillary gel electrophoresis or conventional agarose gel electrophoresis.

By using controlled microbial systems, manufacturers can produce more uniform, highly active polymers with reproducible characteristics, a major advantage in medical aesthetics, where clinicians and patients expect predictable treatment outcomes.

The Challenge of Quality and Polymer Heterogeneity

Despite the promise of biotechnology-derived PNs, analytical and quality-control challenges remain significant. Biomolecules such as DNA-based polymers are inherently complex due to their polymeric structure, heterogeneity, and high molecular weight. Even small variations in manufacturing conditions can influence molecular distribution, fragmentation, purity profiles, and bioactivity.

For aesthetic injectables and regenerative formulations, inconsistent polymer size may impact:

Tissue diffusion behavior
Product viscosity and injectability
Biological stimulation performance
Stability and shelf-life
Safety and immunological response

Traditional analytical methods such as HPLC, UV spectroscopy, or ELISA may struggle to fully characterize complex biomolecular mixtures. As the market for biotechnology-derived aesthetic ingredients expands, more sophisticated analytical techniques are becoming essential to ensure regulatory compliance and product reliability.

MEKC: A Modern Analytical Solution

Micellar Electrokinetic Chromatography (MEKC), an advanced form of capillary electrophoresis, is gaining attention as a powerful analytical tool for complex biomolecules including DNA, collagen, and hyaluronic acid.

MEKC offers several advantages over conventional techniques because it introduces an additional separation mechanism through the use of surfactant-generated micelles. This enables the differentiation of molecules based not only on charge but also on hydrophobic interactions and migration behavior.

In practice, an electric field is applied to a capillary filled with electrolyte buffer. The addition of surfactants such as Sodium Dodecyl Sulfate (SDS) forms negatively charged micelles that interact differently with biomolecules depending on their structure and physicochemical properties.

This allows MEKC to effectively separate and characterize heterogeneous biomolecular populations, making it particularly valuable for PN analysis where purity is a critical quality attribute.

For manufacturers and quality-control laboratories, MEKC can support:

Purity and impurity profiling
Batch consistency verification
Stability assessment
Detection of degradation products
Quantification of complex biomolecule mixtures

As regenerative aesthetics continues to evolve, analytical technologies such as MEKC will play an increasingly important role in ensuring the quality, efficacy, and safety of biotechnology-derived polynucleotide products.

The Future of Regenerative Biomolecules

The rise of polynucleotides reflects a broader transformation in aesthetic medicine toward regenerative, biologically active therapies. Biotechnology enables the development of more sophisticated, sustainable, and reproducible biomolecules, while advanced analytical science is helping ensure that these complex materials meet the highest quality standards.

For cosmetic brands, medical device developers, and aesthetic product manufacturers, success in this fast-growing category will depend not only on innovative ingredients, but also on robust analytical strategies capable of controlling molecular consistency and quality at every stage of production.

If you would like to find out more on related topics please find us online:

Nicholas Hazell

Business Development Manager

Nicholas is Head of Sales and Business Development at Intertek LaCoMeD, where he supports the cosmetics, pharmaceutical, and medical device industries in advancing innovation and ensuring the development of safe, effective products. Drawing on extensive experience across laboratory services and regulatory environments, he works closely with clients to help them navigate R&D, and product validation with rigor and efficiency.